These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2531992)

  • 1. Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study.
    Lorenz M; Hottenrott C; Inglis R; Kirkowa-Reimann M
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3662-71. PubMed ID: 2531992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
    Safi F; Bittner R; Roscher R; Schuhmacher K; Gaus W; Beger GH
    Cancer; 1989 Jul; 64(2):379-87. PubMed ID: 2525415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC; Stagg RJ; Friedman MA; Hannigan JF; Rayner A; Ignoffo RJ; Acord P; Lewis BJ
    J Clin Oncol; 1989 Nov; 7(11):1646-54. PubMed ID: 2530317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.
    Rougier P; Laplanche A; Huguier M; Hay JM; Ollivier JM; Escat J; Salmon R; Julien M; Roullet Audy JC; Gallot D
    J Clin Oncol; 1992 Jul; 10(7):1112-8. PubMed ID: 1296590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
    Patt YZ; Boddie AW; Charnsangavej C; Ajani JA; Wallace S; Soski M; Claghorn L; Mavligit GM
    J Clin Oncol; 1986 Sep; 4(9):1356-64. PubMed ID: 2943876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial.
    Martin JK; O'Connell MJ; Wieand HS; Fitzgibbons RJ; Mailliard JA; Rubin J; Nagorney DM; Tschetter LK; Krook JE
    Arch Surg; 1990 Aug; 125(8):1022-7. PubMed ID: 2143063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.
    Shepard KV; Levin B; Karl RC; Faintuch J; DuBrow RA; Hagle M; Cooper RM; Beschorner J; Stablein D
    J Clin Oncol; 1985 Feb; 3(2):161-9. PubMed ID: 3155793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can the occurrence of extrahepatic metastases in regional chemotherapy of the liver be prevented by adding systemic chemotherapy? A randomized multicenter study].
    Hottenrott C; Lorenz M
    Z Gastroenterol Verh; 1989 Jul; 24():199-201. PubMed ID: 2474952
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.
    Kemeny N; Daly J; Reichman B; Geller N; Botet J; Oderman P
    Ann Intern Med; 1987 Oct; 107(4):459-65. PubMed ID: 2957943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regional chemotherapy of diffuse liver metastases of colorectal cancer].
    Scheele J; Stangl R; Altendorf-Hofmann A; Gall FP
    Zentralbl Chir; 1991; 116(21):1215-35. PubMed ID: 1839115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: influence of modulation with leucovorin.
    Lorenz M; Hottenrott C; Maier P; Reimann M; Inglis R; Encke A
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):163-70. PubMed ID: 1532672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.
    Hohn DC; Rayner AA; Economou JS; Ignoffo RJ; Lewis BJ; Stagg RJ
    Cancer; 1986 Feb; 57(3):465-70. PubMed ID: 2935242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complications of intra-arterial infusion chemotherapy in patients with colorectal cancer with liver metastasis, with special reference to IA-5-FU induced sclerosing cholangitis].
    Sawada T; Hojo K; Moriya Y
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3087-91. PubMed ID: 2506836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial infusion (HAI) chemotherapy for liver metastases of colorectal cancer using 5-FU.
    Schlag P; Hohenberger P; Hölting T; Buhl K; Schwarz V; Herfarth C
    Eur J Surg Oncol; 1990 Apr; 16(2):99-104. PubMed ID: 2323413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer.
    Stagg RJ; Venook AP; Chase JL; Lewis BJ; Warren RS; Roh M; Mulvihill SJ; Grobman BJ; Rayner AA; Hohn DC
    J Natl Cancer Inst; 1991 Mar; 83(6):423-8. PubMed ID: 1825674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrahepatic 5-FU retreatment of liver metastases of colorectal cancer that were progressive under previous systemic chemotherapy.
    Hohenberger P; Schlag P; Herrmann R; Räth U
    Am J Clin Oncol; 1989 Oct; 12(5):447-52. PubMed ID: 2801606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of intra-arterial infusion chemotherapy of colorectal cancer in patients with metastatic liver cancer].
    Sawada T; Hojo K; Moriya Y
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2889-92. PubMed ID: 2506827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Locoregional chemotherapy of hepatic metastases of colorectal cancer].
    Rougier P; Lasser P; Droz JP; Elias D; Ghosn M; Ducreux M; Lumbroso J; Sidibe S
    Ann Gastroenterol Hepatol (Paris); 1987 Nov; 23(6):315-9. PubMed ID: 2962534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Availability of intermittent chemotherapy by reservoir in liver metastasis of colo-rectal cancer].
    Takano S; Fujii M; Teshima Y; Seki N; Yamagata M; Tanaka T; Sakabe T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2871-4. PubMed ID: 2506825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-arterial hepatic chemotherapy for metastatic liver from colo-rectal carcinoma origin.
    Rougier P; Lasser P; Elias D; Ghosn M; Ducreux M; Lumbroso J; Sidibe S; Droz JP
    Sel Cancer Ther; 1989; 5(1):47-54. PubMed ID: 2526963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.